Sanofi: Trump’s Vaccine Policy Won’t Break The Story (NASDAQ:SNY)
seekingalpha.com · 2026-08-24
Sanofi stock faces temporary pressure after Trump’s vaccine order, but trades cheap (9.2x P/E) with raised 2026 guidance. Click for this SNY update.
Read the full story at seekingalpha.com →
Is SNY undervalued? See TickrTrends' fair value analysis →